Skip to main content
Log in

Serum free prostate-specific antigen density (fPSAD) as a predictor of prostate cancer: a new parameter worthy of attention

  • Letter to the Editor
  • Published:
Irish Journal of Medical Science (1971 -) Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Zou BZ, Wen H, Luo HJ et al (2023) Value of serum free prostate-specific antigen density in the diagnosis of prostate cancer. Ir J Med Sci. https://doi.org/10.1007/s11845-023-03448-w. Epub ahead of print. PMID: 37414978

  2. Lin FX, Zhao L, Liu JM  et al (2017) Free prostate specific antigen density predicts prostate cancer with high accuracy. Biomed Res 28:7806–7809

    CAS  Google Scholar 

  3. Siddiqui MR, Ansbro B, Shah PV et al (2023) Real-world use of MRI for risk stratification prior to prostate biopsy. Prostate Cancer Prostatic Dis 26(2):353–359. https://doi.org/10.1038/s41391-022-00543-4. Epub 2022 May 12 PMID: 35551235

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

This work has not been presented anywhere else.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Zhan-Ping Xu.

Ethics declarations

Ethical approval

The authors have no ethical conflicts to disclose.

Informed consent

All authors consent to the publication of the article.

Conflict of interest

The authors have no conflicts of interest to declare.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lin, FX., Xu, ZP. Serum free prostate-specific antigen density (fPSAD) as a predictor of prostate cancer: a new parameter worthy of attention. Ir J Med Sci 193, 627–628 (2024). https://doi.org/10.1007/s11845-023-03533-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11845-023-03533-0

Navigation